Aristotle Atlantic Partners, LLC Guardant Health, Inc. Transaction History

Aristotle Atlantic Partners, LLC

$3.19 Billion
Q3 2024

A detailed history of Aristotle Atlantic Partners, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Aristotle Atlantic Partners, LLC holds 893,508 shares of GH stock, worth $31.1 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

893,508

Previous 749,197 19.26%

Holding current value

$31.1 Million

Previous $21.6 Million 5.31%

% of portfolio

0.64%

Previous 0.7%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$22.3 - $36.29 $3.22 Million - $5.24 Million	144,311 Added 19.26%	893,508 $20.5 Million
Q2 2024 Aug 14, 2024	SELL	$16.07 - $31.84 $927,206 - $1.84 Million	-57,698 Reduced 7.15%	749,197 $21.6 Million
Q1 2024 May 15, 2024	SELL	$17.13 - $26.91 $514,756 - $808,645	-30,050 Reduced 3.59%	806,895 $16.6 Million
Q4 2023 Feb 14, 2024	BUY	$21.58 - $29.5 $61,481 - $84,045	2,849 Added 0.34%	836,945 $22.6 Million
Q3 2023 Nov 14, 2023	SELL	$25.8 - $39.97 $605,577 - $938,175	-23,472 Reduced 2.74%	834,096 $24.7 Million
Q2 2023 Aug 14, 2023	BUY	$20.94 - $38.01 $4.96 Million - $9.01 Million	237,074 Added 38.21%	857,568 $30.7 Million
Q1 2023 May 15, 2023	BUY	$22.92 - $33.76 $39,491 - $58,168	1,723 Added 0.28%	620,494 $14.5 Million
Q4 2022 Feb 14, 2023	BUY	$25.44 - $59.78 $6.05 Million - $14.2 Million	237,627 Added 62.35%	618,771 $16.8 Million
Q3 2022 Nov 14, 2022	BUY	$43.66 - $61.0 $7.51 Million - $10.5 Million	172,050 Added 82.28%	381,144 $20.5 Million
Q2 2022 Aug 15, 2022	BUY	$28.82 - $77.35 $112,225 - $301,200	3,894 Added 1.9%	209,094 $8.44 Million
Q1 2022 May 16, 2022	BUY	$48.25 - $100.49 $137,367 - $286,095	2,847 Added 1.41%	205,200 $13.6 Million
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $658,494 - $893,951	7,423 Added 3.81%	202,353 $20.2 Million
Q3 2021 Nov 15, 2021	BUY	$98.77 - $132.17 $219,565 - $293,813	2,223 Added 1.15%	194,930 $24.4 Million
Q2 2021 Aug 16, 2021	BUY	$109.77 - $165.68 $201,867 - $304,685	1,839 Added 0.96%	192,707 $23.9 Million
Q1 2021 May 17, 2021	BUY	$127.04 - $179.1 $439,812 - $620,044	3,462 Added 1.85%	190,868 $29.1 Million
Q4 2020 Feb 16, 2021	BUY	$99.96 - $135.93 $274,790 - $373,671	2,749 Added 1.49%	187,406 $24.2 Million
Q3 2020 Nov 16, 2020	BUY	$80.32 - $111.8 $125,299 - $174,408	1,560 Added 0.85%	184,657 $20.6 Million
Q2 2020 Aug 14, 2020	BUY	$60.49 - $97.5 $2.17 Million - $3.5 Million	35,855 Added 24.35%	183,097 $14.9 Million
Q1 2020 May 14, 2020	BUY	$59.04 - $88.81 $239,584 - $360,390	4,058 Added 2.83%	147,242 $10.2 Million
Q4 2019 Feb 13, 2020	BUY	$59.49 - $82.78 $5.96 Million - $8.29 Million	100,167 Added 232.85%	143,184 $11.2 Million
Q3 2019 Nov 14, 2019	BUY	$62.59 - $110.3 $63,278 - $111,513	1,011 Added 2.41%	43,017 $2.75 Million
Q2 2019 Aug 13, 2019	BUY	$63.94 - $91.11 $118,352 - $168,644	1,851 Added 4.61%	42,006 $3.63 Million
Q1 2019 May 15, 2019	BUY	$34.3 - $97.98 $1.38 Million - $3.93 Million	40,155 New	40,155 $3.08 Million

Others Institutions Holding GH

# of Institutions

324

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.56B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristotle Atlantic Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristotle Atlantic Partners, LLC with notifications on news.

Account

Aristotle Atlantic Partners, LLC Guardant Health, Inc. Transaction History